Vincerx Pharma, Inc. (VINC) Social Stream
VINCERX PHARMA INC (VINC) Price Targets From Analysts
Use the tables below to see what analysts covering VINCERX PHARMA INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 4 | $33 | $24 | $28.6 | $1.385 | 1964.98% |
| 2021-12-20 | 5 | $30 | $24 | $28 | $1.385 | 1921.66% |
| 2021-12-23 | 6 | $30 | $24 | $27.5 | $1.385 | 1885.56% |
| 2022-01-17 | 6 | $30 | $24 | $27.142 | $1.385 | 1859.71% |
| 2022-03-29 | 6 | $30.001 | $24 | $27.143 | $1.385 | 1859.78% |
| 2022-03-30 | 6 | $30 | $14 | $24.285 | $1.385 | 1653.43% |
| 2022-04-12 | 6 | $30 | $12 | $22.285 | $1.385 | 1509.03% |
| 2022-05-13 | 5 | $30 | $12 | $21.333 | $1.385 | 1440.29% |
| 2022-05-15 | 5 | $30 | $11 | $19 | $1.385 | 1271.84% |
| 2022-06-08 | 4 | $30 | $4 | $13.6 | $1.385 | 881.95% |
| 2022-08-12 | 3 | $19 | $5 | $12 | $1.385 | 766.43% |
| 2022-11-10 | 4 | $19 | $5 | $12 | $1.385 | 766.43% |
| 2022-11-11 | 4 | $19 | $5 | $9.666 | $1.385 | 597.91% |
| 2022-11-17 | 3 | $19 | $3 | $8 | $1.385 | 477.62% |
| 2023-03-29 | 3 | $19 | $5 | $9.666 | $1.385 | 597.91% |
| 2023-08-08 | 2 | $5 | $4 | $4.5 | $1.385 | 224.91% |
| 2023-11-14 | 2 | $4 | $4 | $4 | $1.385 | 188.81% |
The Trend in the Analyst Price Target
Over the past 34 months, VINC's average price target has gone down $29.
VINC reports an average of 492.9% for its upside potential over the past 33 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-29 | 3 | 19 | 5 | 9.666 | 1.020 | 847.65% |
| 2023-03-29 | 3 | 5 | 5 | 5.000 | 1.020 | 390.2% |
| 2023-05-11 | 2 | 5 | 5 | 5.000 | 1.660 | 201.2% |
| 2023-05-12 | 2 | 5 | 5 | 5.000 | 1.630 | 206.75% |
| 2023-08-08 | 2 | 5 | 5 | 5.000 | 0.891 | 461.17% |
VINC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 17 months, VINC's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, VINCERX PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 2405.84% of them.
- VINCERX PHARMA INC's variance in analysts' estimates is lower than -1441.47% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, VINCERX PHARMA INC's number of analysts covering the stock is higher than 491.19% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, VINCERX PHARMA INC's average analyst price target is higher than 713.29% of them.
Stocks similar to VINCERX PHARMA INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ANVS, ETNB, and GRTX.
View All Top Stocks by Price Target
Is VINC a Buy, Hold or Sell? See the POWR Ratings now!